What's new

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised

Jun 5, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Da...

Next Article

Human medicines European public assessment report (EPAR): Beqvez (previously Dur...

Related Posts

COVID-19 vaccines: key facts

COVID-19 vaccines: key facts

May 21, 2025  0

Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Consumer safety of active substances of immunological veterinary medicinal products acting against endogenous targets - Scientific guideline

Consumer safety of active substances of immunological v...

May 23, 2025  0